Behind Arrotex's new sales team

Off the back of Ledaga’s successful launch, Arrotex has been appointed Juniper Biologics' ANZ exclusive partner, with a new specialty sales team already established to support the commercialisation of an innovative range of therapies.

Under the agreement, Arrotex will assume comprehensive sales and marketing responsibilities for the Singapore headquartered company’s portfolio of products in Australia while Juniper Biologics will utilise Arrotex's platform, infrastructure, and operational capabilities.

“We are thrilled to announce our long-term partnership with Juniper Biologics,” Arrotex Chief Commercial Officer, Hayley Tamborini, said.